North America API Market Databank

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2025	MAIN20132989

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2025
SKU	MAIN20132989

The North America API market was valued at $116,178.9 Million in 2025, and is projected to reach $157,492.5 Million by 2032 growing at a CAGR of 4.48% from 2026 to 2032. Captive API manufacturers segment is expected to be the highest contributor to this market, with $66,341.2 Million in 2025, and is anticipated to reach $85,138.8 by 2032, registering a CAGR of 3.66%. Merchant API manufacturers segment is anticipated to reach $72,353.8 Million by 2032 with the highest CAGR of 5.50%.

1. Global API Market, By Type of Manufacturer: 1.1. Overview; 1.2. Captive API manufacturers; 1.2.1 Captive API manufacturers Market, By Region; 1.2.1.1 North America Captive API manufacturers Market, By Country; 1.2.1.2 Europe Captive API manufacturers Market, By Country; 1.2.1.3 Asia-Pacific Captive API manufacturers Market, By Country; 1.2.1.4 LAMEA Captive API manufacturers Market, By Country; 1.3. Merchant API manufacturers; 1.3.1 Merchant API manufacturers Market, By Region; 1.3.1.1 North America Merchant API manufacturers Market, By Country; 1.3.1.2 Europe Merchant API manufacturers Market, By Country; 1.3.1.3 Asia-Pacific Merchant API manufacturers Market, By Country; 1.3.1.4 LAMEA Merchant API manufacturers Market, By Country
2. Global API Market, By Type of Synthesis: 2.1. Overview; 2.2. Synthetic active pharmaceutical ingredients; 2.2.1 Synthetic active pharmaceutical ingredients Market, By Region; 2.2.1.1 North America Synthetic active pharmaceutical ingredients Market, By Country; 2.2.1.2 Europe Synthetic active pharmaceutical ingredients Market, By Country; 2.2.1.3 Asia-Pacific Synthetic active pharmaceutical ingredients Market, By Country; 2.2.1.4 LAMEA Synthetic active pharmaceutical ingredients Market, By Country; 2.3. Biotech active pharmaceutical ingredients; 2.3.1 Biotech active pharmaceutical ingredients Market, By Region; 2.3.1.1 North America Biotech active pharmaceutical ingredients Market, By Country; 2.3.1.2 Europe Biotech active pharmaceutical ingredients Market, By Country; 2.3.1.3 Asia-Pacific Biotech active pharmaceutical ingredients Market, By Country; 2.3.1.4 LAMEA Biotech active pharmaceutical ingredients Market, By Country
3. Global API Market, By Type of Drug: 3.1. Overview; 3.2. Prescription drugs; 3.2.1 Prescription drugs Market, By Region; 3.2.1.1 North America Prescription drugs Market, By Country; 3.2.1.2 Europe Prescription drugs Market, By Country; 3.2.1.3 Asia-Pacific Prescription drugs Market, By Country; 3.2.1.4 LAMEA Prescription drugs Market, By Country; 3.3. Over-the-counter drugs; 3.3.1 Over-the-counter drugs Market, By Region; 3.3.1.1 North America Over-the-counter drugs Market, By Country; 3.3.1.2 Europe Over-the-counter drugs Market, By Country; 3.3.1.3 Asia-Pacific Over-the-counter drugs Market, By Country; 3.3.1.4 LAMEA Over-the-counter drugs Market, By Country
4. Global API Market, By Therapeutic Application: 4.1. Overview; 4.2. Communicable diseases; 4.2.1 Communicable diseases Market, By Region; 4.2.1.1 North America Communicable diseases Market, By Country; 4.2.1.2 Europe Communicable diseases Market, By Country; 4.2.1.3 Asia-Pacific Communicable diseases Market, By Country; 4.2.1.4 LAMEA Communicable diseases Market, By Country; 4.3. Oncology; 4.3.1 Oncology Market, By Region; 4.3.1.1 North America Oncology Market, By Country; 4.3.1.2 Europe Oncology Market, By Country; 4.3.1.3 Asia-Pacific Oncology Market, By Country; 4.3.1.4 LAMEA Oncology Market, By Country; 4.4. Diabetes; 4.4.1 Diabetes Market, By Region; 4.4.1.1 North America Diabetes Market, By Country; 4.4.1.2 Europe Diabetes Market, By Country; 4.4.1.3 Asia-Pacific Diabetes Market, By Country; 4.4.1.4 LAMEA Diabetes Market, By Country; 4.5. Cardiovascular diseases; 4.5.1 Cardiovascular diseases Market, By Region; 4.5.1.1 North America Cardiovascular diseases Market, By Country; 4.5.1.2 Europe Cardiovascular diseases Market, By Country; 4.5.1.3 Asia-Pacific Cardiovascular diseases Market, By Country; 4.5.1.4 LAMEA Cardiovascular diseases Market, By Country; 4.6. Pain management; 4.6.1 Pain management Market, By Region; 4.6.1.1 North America Pain management Market, By Country; 4.6.1.2 Europe Pain management Market, By Country; 4.6.1.3 Asia-Pacific Pain management Market, By Country; 4.6.1.4 LAMEA Pain management Market, By Country; 4.7. Respiratory diseases; 4.7.1 Respiratory diseases Market, By Region; 4.7.1.1 North America Respiratory diseases Market, By Country; 4.7.1.2 Europe Respiratory diseases Market, By Country; 4.7.1.3 Asia-Pacific Respiratory diseases Market, By Country; 4.7.1.4 LAMEA Respiratory diseases Market, By Country; 4.8. Other therapeutic applications; 4.8.1 Other therapeutic applications Market, By Region; 4.8.1.1 North America Other therapeutic applications Market, By Country; 4.8.1.2 Europe Other therapeutic applications Market, By Country; 4.8.1.3 Asia-Pacific Other therapeutic applications Market, By Country; 4.8.1.4 LAMEA Other therapeutic applications Market, By Country
5. Global API Market, By Region: 5.1. Overview; 5.2. North America; 5.2.1 North America API Market, By Type of Manufacturer; 5.2.2 North America API Market, By Type of Synthesis; 5.2.3 North America API Market, By Type of Drug; 5.2.4 North America API Market, By Therapeutic Application; 5.2.5 North America API Market, By Country; 5.2.5.1 US; 5.2.5.1.1 US API Market, By Type of Manufacturer; 5.2.5.1.2 US API Market, By Type of Synthesis; 5.2.5.1.3 US API Market, By Type of Drug; 5.2.5.1.4 US API Market, By Therapeutic Application; 5.2.5.2 Canada; 5.2.5.2.1 Canada API Market, By Type of Manufacturer; 5.2.5.2.2 Canada API Market, By Type of Synthesis; 5.2.5.2.3 Canada API Market, By Type of Drug; 5.2.5.2.4 Canada API Market, By Therapeutic Application; 5.3. 5.4.; Canada API Market Value, By Therapeutic Application, 2025-2032, Million USD